Application of Fusobacterium nucleatum as a biomarker in gastrointestinal malignancies

doi:10.4251/wjgo.v16.i6.2271

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1735)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

HTML

1072

Figures (1-1)

163

Tables (1-2)

161

Sum=1479

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

166

Sum=193

Jun 15, 2024 (publication date) through Jan 7, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2271-2283
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2271

Table 2 The detection efficiency of Fusobacterium nucleatum in different gastrointestinal malignancies samples

Cancer	Samples	Risk assessment and detection rate of F. nucleatum	Method	Ref.
CRC	Tissue	72% (proximal) and 35% (distal)	qPCR	[84]
CRC	Tissue	38.8% (54/139)	ddPCR	[85]
CRC	Tissue	56.30% (18/32)	qPCR	[86]
CRC	Tissue	57.1% (8/14)	AP-PCR	[62]
CRC	Saliva	100% (14/14)	AP-PCR	[62]
CRC	Stool	Worse overall survival	16S rRNA sequencing	[10]
CRC	Tissue	Worse overall survival	16S rRNA sequencing	[10]
CRC	Tissue	50%	PCR	[87]
CRC	Stool	53.5%	PCR	[87]
GC	Tissue	26% (19/80)	qPCR	[88]
GC	Tissue	44% (40/91)	qPCR	[89]
GC	Tissue	28.75% (23/80)	qPCR	[66]
GC	Tissue	Worse overall survival	qPCR	[66]
EC	Tissue	69.4% (68/98)	qPCR	[71]
PC	Tissue	15.5% (13/84)	qRT-PCR	[73]
PC	Serum	52.4%	ELISA and qPCR	[75]

qPCR: Quantitative polymerase chain reaction; ddPCR: Droplet digtial polymerase chain reaction; AP-PCR: Arbitarily primed polymerase chain reaction; qRT-PCR: Quantitative reverse-transcription polymerase chain reaction; ELISA: Enzyme-linked immunosorbent assay; EC: Esophageal cancer; CRC: Colorectal cancer; PC: Pancreatic cancer.

Citation: Yu LC, Li YP, Xin YM, Mao M, Pan YX, Qu YX, Luo ZD, Zhang Y, Zhang X. Application of Fusobacterium nucleatum as a biomarker in gastrointestinal malignancies. World J Gastrointest Oncol 2024; 16(6): 2271-2283
URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2271.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2271